Literature DB >> 27495286

Lipid Emulsion Formulation of Parenteral Nutrition Affects Intestinal Microbiota and Host Responses in Neonatal Piglets.

Celeste M Lavallee1,2, Jayden A R MacPherson1, Mi Zhou1, Yanhua Gao1,3, Pamela R Wizzard2, Paul W Wales1,4, Justine M Turner1,2, Benjamin P Willing1.   

Abstract

BACKGROUND: Total parenteral nutrition (TPN) is a cause of intestinal microbial dysbiosis and impaired gut barrier function. This may contribute to life-threatening parenteral nutrition-associated liver disease and sepsis in infants. We compared the effects of a lipid emulsion containing long-chain ω-3 polyunsaturated fatty acids (PUFAs; SMOFlipid) and a predominantly ω-6 PUFA emulsion (Intralipid) on microbial composition and host response at the mucosal surface.
MATERIALS AND METHODS: Neonatal piglets were provided isocaloric, isonitrogenous TPN for 14 days versus sow-fed (SF) controls. Equivalent lipid doses (10 g/kg/d) were given of either SMOFlipid (ML; n = 10) or Intralipid (SO; n = 9). Ileal segments and mucosal scrapings were used to characterize microbial composition by 16S rRNA gene sequencing and quantitative gene expression of tight junction proteins, mucins, antimicrobial peptides, and inflammatory cytokines.
RESULTS: The microbial composition of TPN piglets differed from SF, while ML and SO differed from each other (analysis of molecular variance; P < .05); ML piglets were more similar to SF, as indicated by UniFrac distance ( P < .05). SO piglets showed a specific and dramatic increase in Parabacteroides ( P < .05), while ML showed an increase in Enterobacteriaceae ( P < .05). Gene expression of mucin, claudin 1, β-defensin 2, and interleukin 8 were higher in TPN; overall increases were significantly less in ML versus SO ( P < .05).
CONCLUSION: The formulation of parenteral lipid is associated with differences in the gut microbiota and host response of TPN-fed neonatal piglets. Inclusion of ω-3 long-chain PUFAs appears to improve host-microbial interactions at the mucosal surface, although mechanisms are yet to be defined.

Entities:  

Keywords:  immune response; infant; life cycle; liver disease; microbiome; neonates; nutrition, lipids; parenteral nutrition; piglet; research and diseases

Mesh:

Substances:

Year:  2016        PMID: 27495286     DOI: 10.1177/0148607116662972

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  5 in total

1.  Parenteral lipids shape gut bile acid pools and microbiota profiles in the prevention of cholestasis in preterm pigs.

Authors:  Lee Call; Tiffany Molina; Barbara Stoll; Greg Guthrie; Shaji Chacko; Jogchum Plat; Jason Robinson; Sen Lin; Caitlin Vonderohe; Mahmoud Mohammad; Dennis Kunichoff; Stephanie Cruz; Patricio Lau; Muralidhar Premkumar; Jon Nielsen; Zhengfeng Fang; Oluyinka Olutoye; Thomas Thymann; Robert Britton; Per Sangild; Douglas Burrin
Journal:  J Lipid Res       Date:  2020-04-29       Impact factor: 5.922

2.  Parenteral Fish-Oil Containing Lipid Emulsions Limit Initial Lipopolysaccharide-Induced Host Immune Responses in Preterm Pigs.

Authors:  William Yakah; David Ramiro-Cortijo; Pratibha Singh; Joanne Brown; Barbara Stoll; Madhulika Kulkarni; Berthe C Oosterloo; Doug Burrin; Krishna Rao Maddipati; Raina N Fichorova; Steven D Freedman; Camilia R Martin
Journal:  Nutrients       Date:  2021-01-12       Impact factor: 5.717

Review 3.  Impact of Parenteral Lipid Emulsion Components on Cholestatic Liver Disease in Neonates.

Authors:  Gregory Guthrie; Douglas Burrin
Journal:  Nutrients       Date:  2021-02-04       Impact factor: 5.717

Review 4.  Parenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota.

Authors:  Monika Cahova; Miriam Bratova; Petr Wohl
Journal:  Nutrients       Date:  2017-09-07       Impact factor: 5.717

5.  Gut microbiota in neonates with congenital gastrointestinal surgical conditions: a prospective study.

Authors:  Shripada C Rao; Meera Esvaran; Sanjay K Patole; Karen N Simmer; Ian Gollow; Anthony Keil; Bernd Wemheuer; Liwei Chen; Patricia L Conway
Journal:  Pediatr Res       Date:  2020-03-16       Impact factor: 3.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.